Toxic or Septic Myocarditis in a Patient Suffering from Aplastic Anemia
Published: 2023-06-02
Page: 179-182
Issue: 2023 - Volume 6 [Issue 1]
Karim Mounaouir *
Cardiology Division, Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Mohammed Nachid
Cardiology Division, Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Ali El Jazouli
Cardiology Division, Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Meryem Haboub
Cardiology Division, Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Arous Salim
Cardiology Division, Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Ghali Bennouna
Cardiology Division, Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Abdenasser Drighil
Cardiology Division, Ibn Rochd University Hospital, Casablanca 20250, Morocco.
Rachida Habbal
Cardiology Division, Ibn Rochd University Hospital, Casablanca 20250, Morocco.
*Author to whom correspondence should be addressed.
Abstract
The present case report highlights about Toxic or septic myocarditis in a patient suffering from aplastic anemia. A 21 years old female patient, without any cardiovascular risk factor, suffering from Aplastic Anemia, admitted initially for feverish neutropenia for which she received adequate antibiotherapy followed by Thymoglobulin® (anti-thymocyte globulin (rabbit)), which is an immunosuppressive agent used in treatment of Aplastic Anemia. Adverse cardiovascular reactions that have been reported in association with ATG include myocarditis, “cardiac irregularity,” chest pain, hypertension, hypotension, tachycardia, and bradycardia.
Keywords: Toxic myocarditis, septic myocarditis, aplastic anemia, myocarditis, chest pain, electrocardiogram, cardiac enzymes, cardiac magnetic resonance imaging, drug reactions.